Semicarbazide-sensitive amine oxidase (SSAO) (EC 1.4.3.6) is widely distributed in nature and catalyzes the oxidative deamination of primary amines. Although SSAO full-length cDNA squences have been reported for some mammalian species, only a partial 5-terminal sequence has been confirmed in the rat. In this study we isolated full-length SSAO cDNA from rat aorta and examined its mRNA expression in various rat tissues by realtime PCR, as well as the subcellular and tissue distributions of SSAO activity. The deduced amino acid sequence showed 91% and 80% identity with mouse and human SSAO, respectively. The mRNA was expressed in many rat tissues. Those findings were supported by the broad distribution of SSAO in the body. Thus, a high level of SSAO was shown in adipocytes by both mRNA expression and enzyme activity measurement. The results suggest that SSAO may play an important role in the degradation of biologically active amines in adipocytes.
The oxidative deamination of many endogenous and xenobiotic amines is catalyzed by a number of amine oxidases (AOs). AOs have traditionally been divided into two major groups, based on the chemical nature of the attached cofactor. One is FAD-containing enzymes (MAO-A and -B). The other group is Cu-containing enzymes (retina amine oxidase (RAO), diamine oxidase (DAO) and semicarbazide-sensitive amine oxidase (SSAO)) in which a TOPA (6-hydroxydopa; 2,3,5-trihydroxyphenylalanine) quinone (TPQ) residue is present as the redox cofactor. 1, 2) These enzymes commonly convert amines to the corresponding aldehydes, simultaneously generating hydrogen peroxide and ammonia. The substrate specificities of both SSAO and MAOs also overlap to some extent (e.g., b-phenylethylamine, serotonin, tryptamine, polyamine and dopamine). SSAO, however, is named after the activity to oxidize benzylamine that remains even after pretreatment with the acetylenic MAO-A and MAO-B inhibitors, clorgyline and deprenyl, respectively.
3) On the other hand, SSAO activity is strongly inhibited by classical carbonyl reagents, typically semicarbazide.
In most mammalians, SSAO exists in membrane-bound and (soluble) plasma forms. However, plasma SSAO appears to be the result of proteolytic cleavage of membrane-bound SSAO, and it has been suggested that the primary source of plasma SSAO is the liver. 4) Ekblom et al. also provided evidence that at least some plasma SSAO may be derived from bone tissue. 5) The functional role of SSAO is still unclear. But interest in the role of SSAO in human physiological conditions has increased in recent years. The activity of SSAO appears to be altered in a number of disease states. For instance, plasma SSAO activity is decreased in subjects suffering from severe burns but increased in cardiac disease. 6, 7) The mechanisms underlying these changes in SSAO activity are also unclear, and it is likely that different processes may be involved.
Membrane-bound SSAO shows a putative transmembrane domain at the N-terminal that is in agreement with its biochemical properties as a membrane protein. 8, 9) SSAO represents an example of a multifunctional membrane protein, as shown by its vascular adhesion properties in addition to its amine oxidase activity. 10, 11) Recently an adhesion protein, vascular adhesion protein-1 (VAP-1), was found to have sequence identity with SSAO at the cDNA level in humans. 10) VAP-1 is an endothelial glycoprotein that involved in the adhesion of lymphocytes to endothelial cells and mediates lymphocyte recirculation in an L-selectin-dependent manner. 12, 13) In human adipocytes, glucose transport is increased in the presence of SSAO substrates alone, suggesting the biological significance of SSAO. 14) This metabolic effect apparently depends on hydrogen peroxide formation, which may regulate trafficking of the glucose transporter GLUT4 to the plasma membrane.
SSAO is present in varying amounts in many mammalian tissues. 15) Relatively high activities of SSAO are associated with cardiovascular smooth muscle cells, adipose tissue, lung and cartilage. It is absent from the nerves and glial cells of the brain, but present in the microvessels of the brain 16) and thus may contribute to the 'blood-brain barrier'. Human SSAO was cloned by two independent groups under two different names, human placental amine oxidase 17) and VAP-1.
10) Later, a retina-specific SSAO with alternative splicing variants (designed RAO) 18, 19) and another SSAO, which is apparently a pseudogene, 20) were reported. Currently, human and murine full-length SSAO cDNA sequences are available.
21) The reported cDNAs encode 763 and 765 amino acids, respectively. As to rat SSAO, only the 5Ј-terminal and a partial amino acid sequence have been known. 22) In this study, we isolated full-length cDNA of rat SSAO using 3Ј-RACE PCR method in order to elucidate its function. Furthermore, we characterized SSAO localization in rat tissue by mRNA expression and enzyme activity.
MATERIALS AND METHODS
Animals 9-week-old male Wistar rats purchased from Japan SLC (200-220 g, Hamamatsu, Japan) were housed at a constant temperature (23Ϯ1°C) and constant humidity (55Ϯ5%) with automatically controlled lighting (07:00-19:00).
3-Rapid-Amplification of cDNA Ends (3RACE) PCR final extension at 72°C for 10 min; and hold at 4°C. The sequences of the primers used were as follows: 5Ј-agctgctctgctcggcctagcgcctgg-3Ј (positions 1-27) for specific primer A, and 5Ј-caggaggagtcctttctggtagaagc-3Ј (positions 39-64) for specific primer B, designed based on the sequence of the known partial gene (GenBank accession no. U72632). Products from 3Ј-RACE PCR were then analyzed on 0.8% agarose gel. The bands were purified using Wizard SV gel and a PCR clean-up system (Promega, Madison, WI, U.S.A.) according to the manufacturer's instructions, and subcloning pCR4-TOPO vector (Invitrogen). Sequences of products were determined using a CEQ 8000 automated DNA sequencer (Beckman-Coulter Inc., Fullerton, CA, U.S.A.) and a DTCS DNA Sequence Kit (Beckman-Coulter) according to the manufacturer's instructions.
cDNA Synthesis from Various Rat Tissues for RealTime PCR For real-time PCR assay, total RNA was extracted from various rat tissues (brain, heart, lung, aorta, stomach, liver, adipocytes, small intestine, large intestine and kidney) using a Wizard SV total RNA extraction kit (Promega) according to the manufacturer's instructions. The RT reaction mixture contained 1 mg of tissue total RNA, 50 ng of random hexamer 1ϫfirst strand buffer, 10 mM dithiothreitol, 0.5 mM of each dNTP, 2.5 mM MgCl 2 and 200 U of a reverse transcriptase (Superscript II, Invitrogen) in a total volume of 20 ml. The mixture was incubated at 42°C for 50 min, heated at 70°C for 15 min to denature the reverse transcriptase, and then cooled to 4°C. The resulting cDNA was stored at Ϫ20°C until use.
Plasmid Construction The full-length ORF SSAOs plasmid was constructed as follows. The SSAO cDNA was PCR-amplified from aorta mRNA using primers Acc65 I-SSAO-F: 5Ј-ggtaccaatgacccagaagaccaccctag-3Ј Not I-SSAO-R: 5Ј-gcggccgcgaattcgcccttccattactccag-3Ј. The amplified DNA fragment was cloned into the pCR4 TOPO vector. These resulting plasmids were cleaved with Acc65 I and Not I, and the resulting DNA fragment was subcloned into the Acc65 I/Not I site of the pcDNA/His MAX A plasmid (Invtrogen).
Cell Cultures and Transfections The African green monkey kidney COS-1 cell line was maintained in DMEM (Sigma St. Louis, MO, U.S.A.) containing 10% FBS (Sigma) and 100 IU/ml penicillin and 100 mg/ml streptomycin (Gibco-BRL Grand Island, NY, U.S.A.) were added to both media. Cells were grown at 37°C in a humidified atmosphere of 5% CO 2 and 95% air. Semiconfluent COS-1 cells were transfected with pcDNA4/His MAX A-SSAO plasmid. As negative control, COS-1 cells were also mock transfected with the unrelated pcDNA/His MAX A plasmid. All plasmids were prepared using the Wizard Pure Fection Plasmid DNA Purification System (Promega) according to the manufacturer's instructions. Cells were transfected using the Lipofectamine 2000 TM reagent (Invitrogen), following the manufacturer's instructions.
Tissue Expression Study by Quantitative Real-Time PCR Quantitative RT-PCR analyses were performed on the cDNA prepared as described above. Forward and reverse primers for real-time PCR amplification were designed using the Primer Express Software (PE Applied Biosystem). The expression levels of rat SSAO were detected using primers SSAO F: 5Ј-gagttgccgacacacactg-3Ј and R: 5Ј-ttcaaccctgccacatcca-3Ј. The expression levels of rat GAPDH were detected using primers GAPDH F: 5Ј-cgaccccttcattgacctca-3Ј and R: 5Ј-ttgactgtgccgttgaacttg-3Ј to normalize the amount of cDNA in the PCRs. The PCR reaction mixtures consisted of 15 ml of 2ϫSYBR green PCR master mix, 0.5 ml of forward primer (20 mM), 0.5 ml of reverse primer (20 mM), 1 ml of 1 : 10 diluted cDNA and 13 ml of ddH 2 O. PCR reactions without cDNA served as template free negative controls. All PCR reactions were performed at 50°C for 2 min and at 95°C for 10 min, followed by 35 cycles of 95°C for 30 s, 60°C for 30 s and 72°C for 30 s in the PE ABI 7700 Sequence Detection System (Perkin-Elmer Life Science, Boston, MA, U.S.A.). A standard curve was generated to determine the amount of template in each reaction. Plasmid DNAs were linearized and quantified by spectrophotometry for amplification. Each PCR was carried out in triplicate, and the dilutions used for SSAO and GAPDH were 10 Ϫ8 -10
Ϫ4
. Enzyme Preparation Various rat tissues were washed in saline (1.15% KCl) and then homogenized in 1 : 9 (w/v) icecold 10 mM Tris-HCl buffer (pH 7.4) containing 0.25 M sucrose and 1 mM EDTA. These crude homogenates were then centrifuged at 600ϫg for 10 min, and the resulting postnuclear supernatants were centrifuged at 9000ϫg for 20 min. The pellet was used as a mitochondrial fraction. Then supernatants were centrifuged at 105000ϫg for 60 min. Each centrifugation procedure was carried out at 4°C. The pellet and supernatant were used as a microsomal fraction and a cytosolic fraction, respectively. These pellets were resuspended in the 200 mM phosphate buffer (pH 7.6). Total protein concentrations were measured by Bradford's method using bovine serum albumin as the standard and a protein assay kit (Dojindo Molecular Technologies, Inc., Gaitherburg, MD, U.S.A.). The fractions were stored at Ϫ80°C until use.
Amine Oxidase Activity Benzylamine hydrochloride was purchased from Sigma. Clorgyline and deprenyl were obtained from Research Biochemical International (Natick, MA, U.S.A.). Semicarbazide, hydrogen peroxide, vanillic acid, 4-aminoantipyrine and peroxidase (type II from horse-radish) were purchased from Wako Pure Chemical Industries, Ltd. (Osaka, Japan). AO activities were measured by a spectrometric method exactly as described by Holt et al. 23) in a volume of 200 ml in 96-well plates using a Model 680 microplate reader (Bio-Rad Laboratories, Hercules, CA, U.S.A.). The substrate concentration was 1 mM, and when necessary the samples were preincubated with amine oxidase inhibitors (1 mM) for 30 min before assay. The AO reaction was initiated by adding the substrate, and after 60-min incubation the absorbance at 490 nm was read.
RESULTS
Cloning and Sequencing of SSAO cDNA from Rat Aorta The full-length cDNA of rat SSAO was isolated from rat aorta using the 3Ј-RACE PCR method (Fig. 1) . The isolated rat SSAO cDNA was 3556 bp in length with 2292 bp of ORF and an initiation codon ATG, and it encoded 763 amino acid residues. This protein displayed the typical features of the copper-containing amine oxidase family. Namely, the pre-TPQ-Tyr was located at position 471 in the amino acid sequence. TPQ-amine oxidases have been shown to contain three histidine residues in the copper-binding domain. In fact, these residues were identified at positions 443, 520 and 522 in the cloned cDNA by site alignment. The deduced amino acid sequences showed high identity with mouse SSAO (91%) and human SSAO (80%). On the other hand, the identity was relatively low with other copper-containing amine oxidases in the rat, i.e., RAO (63%) and DAO (41%), respectively.
Amine Oxidase Activity of Rat SSAO Protein Expression in COS-1 Cell A transient COS-1 cell was obtained by transfection of COS-1 cell with an expression vector containing the SSAO cDNA. Lysates of these cells were assayed for amine oxidase activity using benzylamine as substrate. Negative controls were provided by mock plasmid transfected COS-1 cell lysates. The results showed that the SSAOexpression cells had significant activity toward benzylamine. Mock COS-1 cell lysates showed no detectable activity. In the presence of 100 mM semicarbazide, specific inhibitor of SSAO, AO activity was strongly inhibited. In addition, clorgyline, MAO-A specific inhibitor, did not inhibit SSAO activity. On the other hand, deprenyl, MAO-B specific inhibitor, slightly inhibited SSAO activity (Table 1) .
Tissue Distribution of Rat SSAO mRNA Expression Further investigation of SSAO mRNA expression was performed in rat various tissues by the real-time PCR method. SSAO mRNA was expressed in all tissues studied with adipocytes showing the highest expression. Thereafter, the level of mRNA expression was in the descending order of the lung and aorta (Fig. 2) .
Subcellular Localization of SSAO Activity in Rat Aorta Rat aorta was separated into 3 compartments, consisting of the mitochondria, microsomes and cytosol. These fractions were assayed for amine oxidase activity with benzylamine as the substrate. The amine oxidase activity was highest in the microsomal fraction (Fig. 3) .
The activity was inhibited by semicarbazide, a specific inhibitor of SSAO, but not by clorgyline or deprenyl, specific inhibitors against MAO-A and -B, respectively (Fig. 4) . These results demonstrated that SSAO is localized in the microsomal fraction of the rat aorta and catalyzes oxidative deamination of benzylamine.
Tissue Distribution of Rat SSAO Activity for Benzylamine SSAO activity was investigated in microsomes from several rat tissues. The activity was highest in adipocytes, followed by the aorta, liver and lung, but no activity was detected in the kidney. The SSAO activity in adipocytes was 5-50 fold higher than in the other tissues (Fig. 5) . The results were in good accordance with the tissue distribution of SSAO mRNA expression.
DISCUSSION
SSAO is one of the enzymes responsible for oxidation of amines to aldehydes. As compared to human and mouse SSAO, little is known about the nature of rat SSAO. For example, only partial cDNA to encode 322 amino acids has been reported, although western blot analysis shows 97 kDa protein for SSAO. 22 ) Therefore, we tried to isolate full-length cDNA of rat SSAO to elucidate its physiological role. The determined cDNA sequence was 3556 bp and encoded 763 amino acids; the calculated molecular weight was 85 kDa. The deduced amino acid sequence of rat SSAO showed a signature motif (hydrophobic residues: -Asn-Topa-Asp/Glu-Tyr) at the active site of the enzyme. 24, 25) Tyrosine is always a precursor for the topa in the sequence. There are three conserved histidines in SSAO to bind the copper atom. Two of the histidines are in a His-X-His motif that is located about 50 residues in the C-terminal direction from TPQ cofactor, while the third is situated 20-30 residues toward the N-terminus from the cofactor. Moreover, a conserved Asp residue located about 100 residues in the N-terminal direction from the topa is important, since it serves as a catalytic base in the reductive half-reaction.
We expressed SSAO protein in COS-1 cell. Benzylamine oxidative deamination activity was observed in SSAO protein expression cell. Furthermore, specific inhibitor, semicarbazide, decreased benzylamine oxidative deamination activity. On the other hand MAO-A and -B specific inhibitors, clorgyline and deprenyl respectively, did not inhibit or a little inhibited SSAO activity. These results suggested that our isolated cDNA encoded SSAO protein.
Previously, tissue distribution of SSAO mRNA in rat was tested in Northern analysis using mouse SSAO specific probe by Moldes et al. 21) Certainly, abundant SSAO mRNA was found in adipocytes and aorta in their report. But our results differed with their results in other tissues mRNA expression level. For instance, they reported that liver did not show SSAO mRNA expression level at all. However, in this study, the appreciable mRNA expression level was observed in liver. We considered that the discrepancy was due to the difference in specificity with use of mouse specific probes or rat specific primers.
The microsomal SSAO of human and bovine lung 9, 26) may be important in the metabolism of inhaled volatile amines. 27) In this study, SSAO activities for benzylamine were revealed to be 6-fold higher in microsomes than in the mitochondria of rat aorta. SSAO activity was calculated to cover about 86% in rat aorta total AO activity. As SSAO protein expression in COS-1 was used in inhibition study, the oxidizing activity in aorta was strongly depressed by semicarbazide, a specific inhibitor of SSAO, but not by clorgyline or deprenyl, specific inhibitors of MAO-A and MAO-B, respectively. Benzylamine oxidation activity was detected in many rat tissues. The activity in adipocytes was 5-50 fold higher than in other tissues, while no activity was detected in the kidney.
The expression level was highest in adipocytes, which is in agreement with their high SSAO activity for benzylamine.
The results show that rat SSAO mRNA is abundant in adipocytes, which supports the findings of an earlier paper. 28) Stimulation of glucose transport by benzylamine and tyramine was reported in rat fat cells. 29, 30) This mechanism could involve generation of hydrogen peroxide during oxidative deamination, since the accelerating response was blocked by amine oxidase inhibitors. The ability to stimulate glucose up- take is not a specific function of SSAO, because the hydrogen peroxide formed in MAO-catalyzed reactions can do the same. But correlation between the SSAO activity in adipocytes and glucose uptake may suggest a more specific function for this enzyme.
14,30,31)
Boomsma et al. reported SSAO activity in various species and tissues using benzylamine. Vein exhibited the highest benzylamine oxidative deamination activity in human. In rat, the highest activities were found in artery followed by fat, vein and lung 7) . However, we showed the highest activity in adipocytes in all tissues followed by aorta and liver. The discrepancies between our data and Boomsma's data seemed to be mainly caused by the enzyme source and the existence and absence of inhibitors. Their amine oxidase activity was measured using 3000ϫg supernatant and Triton-treated preparation that contain all kinds of amine oxidase. Moreover, they estimated SSAO activity in the presence of 0.9 mM clorgyline before preincubation. On the other hand, we investigated amine oxidase activity using microsomes fraction, in which SSAO of plasma membrane and vesicle was involved, and in the absence of inhibitors. We speculated our data reflected nearly natural SSAO activity because of a strongly relationship coefficient (R 2 ϭ0.956) between SSAO mRNA expression level and SSAO activity.
Human SSAO was cloned as placental amine oxidase and VAP-1. They are identical in facts. 10, 11) A splicing variant RAO and another pseudogene SSAO have been reported. [17] [18] [19] [20] Furthermore, there is genetic evidence for the presence of at least three SSAOs in bovine tissues. 32) In this report, rat liver showed appreciable mRNA expression but comparatively moderate activity of SSAO. The discrepancy in the mRNA level and enzyme activity in rat liver may suggest another kind of SSAO molecule other than the already reported DAO and SSAO as copper-containing amine oxidases.
In conclusion, to elucidate the function of SSAO we iso- Figure 2A shows the high level of mRNA expression tissues and Fig. 2B shows the low level of mRNA expression tissues. Total RNAs were isolated from 10 tissues. First-strand cDNAs were synthesized as described under Materials and Methods. Subsequently, real-time PCR was performed using the cDNA as the template and gene-specific primers. The data were normalized to GAPDH. Each bar represents the meanϮS.E. of 3 determinations. AO activities were measured as described under Materials and Methods in SSAO cDNA-and mock-transfected COS-1 cell lysates using benzylamine as substrate, which was also assayed in the presence of an SSAO inhibitor (semicarbazide, 100 mM), a MAO-A inhibitor (clorgyline, 1 mM) or a MAO-B inhibitor (deprenyl, 1 mM). The results are expressed as nmol of H 2 O 2 /mg protein/min and represent the meanϮS.E. of 3 determinations. N.D.: not detected.
Fig. 3. Subcellular Localization of SSAO Activity in Rat Aorta
Rat aorta was separated into three compartments (microsomes, mitochondria and cytosol). SSAO activities were measured as described under Materials and Methods. The results are expressed as nmol of H 2 O 2 /mg protein/min and represent the meanϮS.E. of 3 determinations. * pϽ0.001 when compared to microsomes. lated full-length rat SSAO cDNA consisting of 3556 bp, whose deduced amino acid sequence showed high identity to other SSAOs. Rat adipocytes showed a high level of mRNA expression together with a high level of enzyme activity, suggesting an important role of SSAO in regulating glucose metabolism in adipocytes. The molecular aspects of rat SSAO revealed here may help answer many physiological and pathophysiological questions about SSAO.
